Boston Scientific Corp. Company Profile (NYSE:BSX)

About Boston Scientific Corp.

Boston Scientific Corp. logoBoston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP), Endoscopy, Urology and Pelvic Health, and Neuromodulation. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and PI businesses. Its Rhythm Management segment consists of CRM and EP businesses. Its MedSurg segment consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its interventional cardiology products include Drug-Eluting Coronary Stent Systems, Core Coronary Technology, Intravascular Imaging and Structural Heart Therapy. Its peripheral products include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: BSX
  • CUSIP: 10113710
Key Metrics:
  • Previous Close: $22.44
  • 50 Day Moving Average: $23.436
  • 200 Day Moving Average: $22.942
  • 52-Week Range: $15.67 - $24.79
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 17.81
  • P/E Growth: 1.720
  • Market Cap: $30.47B
  • Outstanding Shares: 1,360,743,000
  • Beta: 0.89
  • Net Margins: -4.34%
  • Return on Equity: 22.66%
  • Return on Assets: 8.01%
  • Debt-to-Equity Ratio: 0.83%
  • Current Ratio: 1.05%
  • Quick Ratio: 0.74%
Additional Links:
Companies Related to Boston Scientific Corp.:

Analyst Ratings

Consensus Ratings for Boston Scientific Corp. (NYSE:BSX) (?)
Ratings Breakdown: 4 Hold Ratings, 20 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $25.40 (13.19% upside)

Analysts' Ratings History for Boston Scientific Corp. (NYSE:BSX)
DateFirmActionRatingPrice TargetDetails
10/14/2016Royal Bank Of CanadaReiterated RatingOutperform$28.00View Rating Details
10/6/2016Citigroup Inc.Boost Price TargetBuy$28.00 -> $29.00View Rating Details
9/1/2016ArgusUpgradeHold -> Buy$23.82 -> $33.00View Rating Details
7/31/2016Evercore ISIReiterated RatingBuy$25.50 -> $26.00View Rating Details
7/29/2016RBC Capital MarketsReiterated RatingBuy$28.00View Rating Details
7/29/2016JPMorgan Chase & Co.Boost Price TargetOverweight$24.00 -> $27.00View Rating Details
7/29/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details
7/29/2016Leerink SwannReiterated RatingBuyView Rating Details
7/29/2016Jefferies GroupBoost Price TargetHold$21.00 -> $24.00View Rating Details
7/29/2016WedbushBoost Price TargetNeutral$23.00 -> $25.00View Rating Details
7/29/2016Needham & Company LLCBoost Price TargetBuy$26.00 -> $28.00View Rating Details
7/28/2016Benchmark Co.Boost Price TargetBuy$25.00 -> $31.00View Rating Details
6/21/2016Piper Jaffray Cos.Reiterated RatingOverweight$26.00View Rating Details
6/8/2016GuggenheimInitiated CoverageBuy$26.00View Rating Details
5/23/2016BTIG ResearchDowngradeBuy -> Neutral$24.20View Rating Details
4/28/2016Barclays PLCBoost Price TargetOverweight$23.00 -> $25.00View Rating Details
4/28/2016Stifel NicolausBoost Price TargetBuy$22.00 -> $25.00View Rating Details
4/8/2016Goldman Sachs Group Inc.Boost Price Target$21.00 -> $22.00View Rating Details
3/27/2016Morgan StanleyReiterated RatingOverweight$22.00View Rating Details
3/25/2016Bank of America Corp.Reiterated RatingBuy$23.00View Rating Details
3/18/2016Longbow ResearchInitiated CoverageBuyView Rating Details
3/17/2016NomuraInitiated CoverageBuy$22.00View Rating Details
3/12/2016Deutsche Bank AGReiterated RatingHoldView Rating Details
2/25/2016SunTrust Banks Inc.Initiated CoverageBuy$21.00View Rating Details
1/4/2016Sterne Agee CRTBoost Price TargetBuy$21.00 -> $22.50View Rating Details
7/7/2015StephensInitiated CoverageOverweight$21.00View Rating Details
3/20/2015Raymond James Financial Inc.Initiated CoverageOutperform$21.00View Rating Details
3/16/2015BMO Capital MarketsBoost Price TargetOutperform$18.00 -> $19.00View Rating Details
3/3/2015Oppenheimer Holdings Inc.Boost Price TargetMarket Perform$16.00 -> $17.00View Rating Details
2/5/2015JMP SecuritiesBoost Price TargetMarket Outperform$15.00 -> $17.00View Rating Details
2/5/2015CRT CapitalBoost Price TargetBuy$16.00 -> $18.00View Rating Details
(Data available from 10/26/2014 forward)


Earnings History for Boston Scientific Corp. (NYSE:BSX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2016Q316$0.27$0.27$2.07 billion$2.11 billionViewListenView Earnings Details
7/28/2016Q216$0.27$0.27$2.05 billion$2.13 billionViewListenView Earnings Details
4/27/2016Q116$0.24$0.28$1.91 billion$1.96 billionViewListenView Earnings Details
2/4/2016Q415$0.25$0.26$2.00 billion$1.98 billionViewListenView Earnings Details
10/28/2015Q315$0.23$0.24$1.86 billion$1.89 billionViewListenView Earnings Details
7/23/2015Q215$0.21$0.22$1.83 billion$1.84 billionViewListenView Earnings Details
4/28/2015Q115$0.21$0.21$1.78 billion$1.77 billionViewListenView Earnings Details
2/4/2015Q414$0.21$0.22$1.91 billion$1.89 billionViewListenView Earnings Details
10/22/2014Q314$0.20$0.20$1.82 billion$1.85 billionViewListenView Earnings Details
7/24/2014Q214$0.19$0.18$1.87 billion$1.87 billionViewListenView Earnings Details
4/29/2014Q114$0.18$0.16$1.80 billion$1.77 billionViewListenView Earnings Details
2/4/2014Q4$0.13$0.21$1.83 billion$1.84 billionViewListenView Earnings Details
10/24/2013Q313$0.09$0.17$1.73 billion$1.74 billionViewListenView Earnings Details
7/25/2013Q2 2013$0.10$0.18$1.78 billion$1.81 billionViewListenView Earnings Details
4/25/2013Q1 2013$0.09$0.16$1.79 billion$1.76 billionViewListenView Earnings Details
1/29/2013Q4 2012$0.11$0.18$1.76 billion$1.82 billionViewListenView Earnings Details
10/18/2012$0.11($0.52)ViewN/AView Earnings Details
7/26/2012$0.08$0.17ViewN/AView Earnings Details
4/19/2012$0.13$0.15ViewN/AView Earnings Details
2/2/2012$0.08$0.07ViewN/AView Earnings Details
10/20/2011$0.09$0.15ViewN/AView Earnings Details
7/28/2011$0.08$0.17ViewN/AView Earnings Details
4/20/2011$0.04$0.01ViewN/AView Earnings Details
2/1/2011$0.09$0.15ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Boston Scientific Corp. (NYSE:BSX)
Current Year EPS Consensus Estimate: $1.1 EPS
Next Year EPS Consensus Estimate: $1.26 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.24$0.24$0.24
Q2 20165$0.26$0.27$0.26
Q3 20164$0.26$0.27$0.27
Q4 20165$0.28$0.29$0.29
Q1 20172$0.30$0.30$0.30
Q2 20172$0.30$0.32$0.31
Q3 20172$0.31$0.32$0.32
Q4 20172$0.33$0.34$0.34
(Data provided by Zacks Investment Research)


Dividend History for Boston Scientific Corp. (NYSE:BSX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Boston Scientific Corp. (NYSE:BSX)
Insider Ownership Percentage: 1.31%
Institutional Ownership Percentage: 92.22%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2016John Bradley SorensonSVPSell2,500$23.90$59,750.00View SEC Filing  
8/1/2016Michael F MahoneyCEOSell44,400$24.44$1,085,136.00View SEC Filing  
8/1/2016Timothy A PrattEVPSell24,000$24.46$587,040.00View SEC Filing  
7/20/2016David A PierceSVPSell2,480$24.03$59,594.40View SEC Filing  
7/20/2016Michael P. PhalenEVPSell35,000$24.03$841,050.00View SEC Filing  
6/1/2016Michael F MahoneyCEOSell100,000$22.69$2,269,000.00View SEC Filing  
6/1/2016Timothy A PrattEVPSell24,229$22.66$549,029.14View SEC Filing  
5/11/2016John Bradley SorensonSVPSell2,800$22.15$62,020.00View SEC Filing  
5/10/2016Keith D DawkinsEVPSell80,000$22.15$1,772,000.00View SEC Filing  
5/6/2016Jeffrey B MirvissSVPSell24,659$21.94$541,018.46View SEC Filing  
5/3/2016Joseph Michael FitzgeraldEVPSell79,960$21.81$1,743,927.60View SEC Filing  
5/2/2016Michael F MahoneyCEOSell100,000$22.12$2,212,000.00View SEC Filing  
5/2/2016Timothy A PrattEVPSell24,000$21.93$526,320.00View SEC Filing  
4/27/2016Kevin J BallingerSVPSell111,807$21.62$2,417,267.34View SEC Filing  
4/27/2016Timothy A PrattEVPSell39,927$21.40$854,437.80View SEC Filing  
4/4/2016Jeffrey B MirvissSVPSell18,422$19.00$350,018.00View SEC Filing  
4/1/2016Michael F MahoneyCEOSell100,000$18.90$1,890,000.00View SEC Filing  
4/1/2016Timothy A PrattEVPSell24,000$18.73$449,520.00View SEC Filing  
3/11/2016Kevin J BallingerSVPSell16,705$18.00$300,690.00View SEC Filing  
3/8/2016Karen PrangeSVPSell14,747$17.27$254,680.69View SEC Filing  
3/2/2016Michael P. PhalenEVPSell10,665$17.17$183,118.05View SEC Filing  
3/1/2016Michael F MahoneyCEOSell100,000$16.96$1,696,000.00View SEC Filing  
3/1/2016Timothy A PrattEVPSell15,068$16.97$255,703.96View SEC Filing  
2/29/2016Kevin J. BallingerSVPSell2,114$17.17$36,297.38View SEC Filing  
2/29/2016Michael P. PhalenEVPSell1,819$17.19$31,268.61View SEC Filing  
2/25/2016Daniel J BrennanCFOSell103,211$17.22$1,777,293.42View SEC Filing  
2/25/2016Kevin J. BallingerSVPSell1,903$17.48$33,264.44View SEC Filing  
2/25/2016Michael P. PhalenEVPSell34,106$17.28$589,351.68View SEC Filing  
2/17/2016Kevin J. BallingerSVPSell7,616$17.37$132,289.92View SEC Filing  
2/12/2016Charles J DockendorffDirectorBuy30,000$16.49$494,700.00View SEC Filing  
2/8/2016Karen PrangeSVPSell6,216$16.05$99,766.80View SEC Filing  
1/8/2016Timothy A PrattEVPSell7,160$17.67$126,517.20View SEC Filing  
1/7/2016Kevin J BallingerSVPSell19,059$17.73$337,916.07View SEC Filing  
1/5/2016Jeffrey B MirvissSVPSell9,953$18.00$179,154.00View SEC Filing  
12/1/2015Timothy A. PrattEVPSell24,000$18.43$442,320.00View SEC Filing  
11/16/2015Ernest MarioDirectorSell125,000$17.63$2,203,750.00View SEC Filing  
11/9/2015John Bradley SorensonSVPSell4,469$18.68$83,480.92View SEC Filing  
11/9/2015Joseph Michael FitzgeraldEVPSell26,220$18.58$487,167.60View SEC Filing  
11/5/2015Timothy A PrattEVPSell19,598$19.00$372,362.00View SEC Filing  
10/28/2015Jeffrey B MirvissSVPSell9,492$18.00$170,856.00View SEC Filing  
10/28/2015Timothy A PrattEVPSell3,500$18.00$63,000.00View SEC Filing  
10/5/2015Timothy A PrattEVPSell3,500$17.34$60,690.00View SEC Filing  
10/1/2015Timothy A. PrattEVPSell17,000$16.33$277,610.00View SEC Filing  
8/21/2015John E AbeleDirectorBuy200,000$16.77$3,354,000.00View SEC Filing  
8/19/2015John E AbeleDirectorBuy200,000$17.48$3,496,000.00View SEC Filing  
8/17/2015John E AbeleDirectorBuy100,000$17.50$1,750,000.00View SEC Filing  
7/7/2015Karen PrangeSVPSell17,456$17.66$308,272.96View SEC Filing  
5/29/2015Maulik NanavatySVPSell71,558$18.52$1,325,254.16View SEC Filing  
5/28/2015Wendy CarruthersSVPSell42,281$17.91$757,252.71View SEC Filing  
5/18/2015Ernest MarioDirectorSell50,000$18.09$904,500.00View SEC Filing  
5/14/2015John E SununuDirectorSell10,000$17.87$178,700.00View SEC Filing  
5/11/2015John Bradley SorensonSVPSell8,735$17.49$152,775.15View SEC Filing  
3/20/2015David A PierceSVPSell18,050$18.00$324,900.00View SEC Filing  
3/20/2015Michael P PhalenEVPSell46,085$17.94$826,764.90View SEC Filing  
3/16/2015Michael P PhalenEVPSell30,022$17.18$515,777.96View SEC Filing  
3/13/2015John Bradley SorensonSVPSell3,830$16.84$64,497.20View SEC Filing  
3/9/2015David A PierceSVPSell2,561$16.54$42,358.94View SEC Filing  
3/3/2015David A PierceSVPSell8,983$16.79$150,824.57View SEC Filing  
3/3/2015Michael P PhalenEVPSell12,768$16.79$214,374.72View SEC Filing  
2/27/2015David A PierceSVPSell19,046$16.80$319,972.80View SEC Filing  
2/27/2015Michael P PhalenEVPSell1,819$16.80$30,559.20View SEC Filing  
2/19/2015David A PierceSVPSell11,958$16.46$196,828.68View SEC Filing  
2/19/2015Michael P PhalenEVPSell13,188$16.44$216,810.72View SEC Filing  
2/10/2015Joseph Michael FitzgeraldEVPSell61,208$14.66$897,309.28View SEC Filing  
2/9/2015David A PierceSVPSell5,000$14.66$73,300.00View SEC Filing  
2/6/2015Kevin J BallingerSVPSell21,408$15.06$322,404.48View SEC Filing  
1/20/2015Michael P PhalenEVPSell10,000$14.54$145,400.00View SEC Filing  
1/8/2015David A PierceSVPSell18,612$14.31$266,337.72View SEC Filing  
1/8/2015Michael P PhalenEVPSell27,589$14.31$394,798.59View SEC Filing  
1/5/2015Michael P PhalenEVPSell10,000$13.75$137,500.00View SEC Filing  
12/10/2014Karen PrangeSVPSell19,753$12.64$249,677.92View SEC Filing  
12/8/2014David A PierceSVPSell5,000$12.90$64,500.00View SEC Filing  
12/1/2014Ernest MarioDirectorSell10,000$12.96$129,600.00View SEC Filing  
11/28/2014Michael F MahoneyCEOBuy11,700$12.89$150,813.00View SEC Filing  
11/10/2014Edward J LudwigDirectorBuy10,000$13.38$133,800.00View SEC Filing  
11/5/2014John E SununuDirectorSell8,997$13.38$120,379.86View SEC Filing  
11/3/2014Ernest MarioDirectorSell10,000$13.30$133,000.00View SEC Filing  
10/8/2014Ernest MarioDirectorSell10,000$12.06$120,600.00View SEC Filing  
9/2/2014Ernest MarioDirectorSell10,000$12.60$126,000.00View SEC Filing  
8/15/2014Michael P PhalenEVPSell11,471$12.58$144,305.18View SEC Filing  
8/1/2014Ernest MarioDirectorSell10,000$12.58$125,800.00View SEC Filing  
7/30/2014David A PierceSVPSell157$12.97$2,036.29View SEC Filing  
7/15/2014Michael P PhalenEVPSell67,500$13.04$880,200.00View SEC Filing  
7/1/2014Ernest MarioDirectorSell10,000$12.95$129,500.00View SEC Filing  
6/16/2014Michael P PhalenEVPSell13,500$13.02$175,770.00View SEC Filing  
6/2/2014Ernest MarioDirectorSell10,000$12.88$128,800.00View SEC Filing  
5/15/2014Michael PhalenEVPSell13,500$12.76$172,260.00View SEC Filing  
5/1/2014Ernest MarioDirectorSell10,000$12.58$125,800.00View SEC Filing  
4/15/2014Michael PhalenEVPSell13,500$13.25$178,875.00View SEC Filing  
4/1/2014Ernest MarioDirectorSell10,000$13.55$135,500.00View SEC Filing  
3/17/2014Michael PhalenEVPSell13,500$13.05$176,175.00View SEC Filing  
3/6/2014David PierceSVPSell5,316$13.44$71,447.04View SEC Filing  
3/6/2014Michael PhalenEVPSell7,281$13.44$97,856.64View SEC Filing  
2/27/2014David PierceSVPSell2,057$13.29$27,337.53View SEC Filing  
2/27/2014Michael PhalenEVPSell3,166$13.29$42,076.14View SEC Filing  
2/21/2014David PierceSVPSell3,199$13.22$42,290.78View SEC Filing  
2/21/2014Michael PhalenEVPSell3,222$13.22$42,594.84View SEC Filing  
2/18/2014Michael PhalenEVPSell13,500$13.30$179,550.00View SEC Filing  
2/13/2014Kristina JohnsonDirectorSell18,000$13.01$234,180.00View SEC Filing  
2/6/2014Ernest MarioDirectorSell17,104$12.80$218,931.20View SEC Filing  
2/3/2014Ernest MarioDirectorSell10,000$13.19$131,900.00View SEC Filing  
1/6/2014Ernest MarioDirectorSell10,000$12.50$125,000.00View SEC Filing  
12/26/2013Ernest MarioDirectorSell10,000$12.06$120,600.00View SEC Filing  
11/26/2013Jeffrey CapelloCFOSell85,106$11.82$1,005,952.92View SEC Filing  
11/11/2013Jeffrey MirvissSVPSell26,000$11.91$309,660.00View SEC Filing  
8/29/2013Jeffrey CapelloCFOSell525,000$10.68$5,607,000.00View SEC Filing  
8/16/2013Joseph Michael FitzgeraldSVPSell9,202$11.02$101,406.04View SEC Filing  
8/14/2013Kevin BallingerSVPSell38,171$11.28$430,568.88View SEC Filing  
5/31/2013Jeffrey B MirvissSVPSell10,941$9.37$102,517.17View SEC Filing  
5/30/2013Wendy CarruthersSVPSell25,001$9.16$229,009.16View SEC Filing  
5/29/2013Nelda J ConnorsDirectorSell24,116$9.17$221,143.72View SEC Filing  
5/6/2013Ernest MarioDirectorBuy30,000$7.76$232,800.00View SEC Filing  
11/13/2012Nj Nicholas JrDirectorBuy20,000$5.28$105,600.00View SEC Filing  
11/9/2012Nj Nicholas JrDirectorBuy25,000$5.17$129,250.00View SEC Filing  
8/6/2012Ernest MarioDirectorBuy32,000$5.29$169,280.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Boston Scientific Corp. (NYSE:BSX)
DateHeadline logoBoston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation - (NYSE:BSX) - October 26 at 12:20 PM logoBoston Scientific Remains Flat After Meeting Earnings (NYSE:BSX) - October 26 at 12:20 PM logoBoston Scientific To Participate In 25th Annual Credit Suisse ... - PR Newswire (press release) (NYSE:BSX) - October 25 at 4:01 PM logoTrader's Round Up: Huntington Bancshares Incorporated (HBAN), Boston Scientific Corporation (BSX), CIT Group Inc ... - iStreetWire (NYSE:BSX) - October 25 at 4:01 PM
News IconNewsmaking Penny Stock: Investors Checking Out Boston Scientific Corporation (NYSE:BSX) - Duncan Research (NYSE:BSX) - October 25 at 4:01 PM logoWhat to Look for When Boston Scientific (BSX) Reports Q3 Earnings (NYSE:BSX) - October 25 at 4:01 PM
News IconNoteworthy Movers: Boston Scientific Corporation (NYSE:BSX), CIT Group Inc. (NYSE:CIT) - The Newburgh Press (NYSE:BSX) - October 25 at 8:52 AM logoBoston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2016 (NYSE:BSX) - October 25 at 8:52 AM logoBoston Scientific To Participate In 25th Annual Credit Suisse Healthcare Conference (NYSE:BSX) - October 25 at 8:52 AM logoStocks In Action: Boston Scientific Corporation (BSX), Texas Instruments Inc. (TXN), NVIDIA Corporation (NVDA) - iStreetWire (NYSE:BSX) - October 24 at 3:56 PM
News IconEffective Mover to See- Boston Scientific Corporation's (BSX) - Hot Stocks Point (NYSE:BSX) - October 24 at 3:56 PM
News Icon13F Action: Deroy & Devereaux Private Investment Counsel INC Has Trimmed Its Position in Boston Scientific Corp ... - Chester News (NYSE:BSX) - October 24 at 3:56 PM
News IconMedical Appliances & Equipment: Boston Scientific Corporation (NYSE:BSX) Position of the day (NYSE:BSX) - October 23 at 3:53 PM
News IconBoston Scientific Corporation (NYSE: BSX) – Is this large market cap stock undervalued? - The Daily Leicester (NYSE:BSX) - October 22 at 8:17 AM
News IconIt's Earnings Time: What to Do with Boston Scientific Corporation (NYSE:BSX) Stock - The Voice Registrar (NYSE:BSX) - October 21 at 3:59 PM
News IconSafe Haven Profitability Portfolio Stocks: Boston Scientific ... - Street Wise Report (press release) (blog) (NYSE:BSX) - October 21 at 12:16 PM
News IconAnalysts Opinions Crush Stocks Estimates: Boston Scientific Corporation (NYSE:BSX), Illumina Inc. (NASDAQ:ILMN) - Seneca Globe (NYSE:BSX) - October 21 at 12:16 PM
News IconStocks Retreating on New Evolution: Boston Scientific Corporation (NYSE:BSX), Tenet Healthcare Corp. (NYSE:THC) - Street Wise Report (press release) (blog) (NYSE:BSX) - October 20 at 3:29 PM logoWhat's in Store for Boston Scientific's (BSX) Q3 Earnings? - Nasdaq (NYSE:BSX) - October 20 at 3:29 PM
News IconCisco Systems, Inc. (NASDAQ:CSCO) & Boston Scientific Corporation (NYSE:BSX) News Recap - Money News (NYSE:BSX) - October 20 at 8:47 AM logoBoston Scientific Unveils Improved Endoclip (BSX) - Investopedia (NYSE:BSX) - October 20 at 8:47 AM logoWhat's in Store for Boston Scientific's (BSX) Q3 Earnings? (NYSE:BSX) - October 20 at 8:47 AM
News IconStocks Roundup - Freeport-McMoRan, (NYSE:FCX), Boston Scientific Corporation, (NYSE:BSX) - Financial Breaking News (NYSE:BSX) - October 19 at 3:50 PM logoStocks Buzz: CVS Health Corporation (CVS) Boston Scientific Corporation (BSX) Juniper Networks, Inc. (JNPR) - iStreetWire (NYSE:BSX) - October 19 at 3:50 PM logoBoston Scientific Clip Can Ease GI Bleeding (BSX) (NYSE:BSX) - October 19 at 3:50 PM logoInteresting BSX Put And Call Options For January 2019 (NYSE:BSX) - October 19 at 8:53 AM
News IconStock Perspective: Boston Scientific Corporation (NYSE:BSX) Company Earnings Watch (NYSE:BSX) - October 19 at 8:53 AM
News IconInvestors Catching Stocks: Boston Scientific Corporation (NYSE:BSX) (NYSE:BSX) - October 19 at 8:53 AM
News IconTop Gainers of the Day: Boston Scientific Corporation (NYSE:BSX) from Medical Appliances & Equipment (NYSE:BSX) - October 19 at 8:53 AM
News IconStocks Tumbling on Lethargic Results: Boston Scientific Corporation (NYSE:BSX), Hologic Inc. (NASDAQ:HOLX) - Street Wise Report (press release) (blog) (NYSE:BSX) - October 18 at 3:56 PM
News IconInvestments Worthy Stocks: Boston Scientific Corporation (NYSE:BSX), Tenet Healthcare Corp. (NYSE:THC) - Street Wise Report (press release) (blog) (NYSE:BSX) - October 18 at 3:56 PM
News IconFilings Worth Watching: Boston Scientific Corp (BSX) Shareholder Orbimed Advisors LLC Raised Holding as Market ... - Chester News (NYSE:BSX) - October 18 at 3:56 PM logoBoston Scientific Launches Resolution 360™ Clip - PR Newswire - PR Newswire (press release) (NYSE:BSX) - October 18 at 8:51 AM logoStocks in Review: American International Group, Inc. (AIG), Boston Scientific Corporation (BSX), Twilio, Inc. (TWLO) - iStreetWire (NYSE:BSX) - October 18 at 8:51 AM logoStocks In Queue: NIKE, Inc. (NKE), Boston Scientific Corporation (BSX), GoPro, Inc. (GPRO) - iStreetWire (NYSE:BSX) - October 17 at 8:51 AM logoSteady Movements Boston Scientific Corporation (NYSE:BSX), Allergan plc Ordinary Shares (NYSE:AGN) - Wall Street 24 (NYSE:BSX) - October 17 at 8:51 AM logoBoston Scientific Launches Resolution 360™ Clip (NYSE:BSX) - October 17 at 8:51 AM
News IconStocks to Watch – Boston Scientific Corporation, (NYSE:BSX ... - Money News (NYSE:BSX) - October 15 at 3:52 PM logoBoston Scientific Corporation (NYSE:BSX) Top Yearly EPS Estimate Of $1.17? - Stocks Daily (NYSE:BSX) - October 15 at 3:52 PM logoStocks Alert: Novavax, Inc. (NVAX), Boston Scientific Corporation (BSX), Exxon Mobil Corporation (XOM) - iStreetWire (NYSE:BSX) - October 14 at 3:53 PM
News IconVolume Buzzers on Charts: Boston Scientific Corporation (NYSE ... - Street Wise Report (press release) (blog) (NYSE:BSX) - October 14 at 3:53 PM logo3 Big-Cap Stocks That Are Growing Again (NYSE:BSX) - October 14 at 12:27 PM logoUptrend Call Working As Boston Scientific Stock Rises 28.6% (BSX) (NYSE:BSX) - October 13 at 3:54 PM
News IconHigh Market Cap Stock of the Day – Boston Scientific Corporation (NYSE:BSX) (NYSE:BSX) - October 13 at 3:54 PM
News IconBoston Scientific Corp. (BSX) PT Raised to $29.00 (NYSE:BSX) - October 13 at 10:20 AM logoHealthcare Stocks Technical Reports -- Abbott Laboratories, Boston Scientific, Perrigo, and Second Sight Medical (NYSE:BSX) - October 13 at 10:20 AM logoBoston Scientific : Competition Seeks Concepts Applying Analytics to Big Data for Better Patient Outcomes (NYSE:BSX) - October 13 at 10:20 AM logoBoston Scientific Competition Seeks Concepts Applying Analytics to Big Data for Better Patient Outcomes (NYSE:BSX) - October 13 at 10:20 AM
News IconSell-side Taking Aim at Shares of Boston Scientific Corporation (NYSE:BSX) - CSZ News (NYSE:BSX) - October 12 at 4:12 PM
News IconNoteworthy Analyst Ratings of Two Stocks Coty Inc (NYSE:COTY ... - The Voice Registrar (NYSE:BSX) - October 11 at 4:04 PM


Boston Scientific Corp. (NYSE:BSX) Chart for Wednesday, October, 26, 2016

Last Updated on 10/26/2016 by Staff